Молекулярные механизмы действия ДИМ и его клиническое применение

Оптимальное питание предусматривает необходимость и обязательность полного обеспечения потребностей организма не только в энергии, макро- и микронутриентах, но и в минорных биологически активных веществах. Одними из наиболее перспективных хемопротекторов являются глюкозинолаты и их активные производные, такие как 3,3’-дииндолилметан (ДИМ). ДИМ обладает способностью тормозить развитие и прогрессирование неоплазии за счет регуляции множества внутриклеточных сигнальных путей. В настоящее время проводится изучение клинической эффективности ДИМ при раке молочной железы и простаты, а также исследуется возможность применения антиоксидантных и противовоспалительных свойств ДИМ при нейродегенеративных, метаболических и иммунных заболеваниях.

1. Noncommunicable diseases. WHO. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

2. Рак молочной железы. Информационные бюллетени ВОЗ. 13 марта 2024 г. https://www.who.int/ru/news-room/fact-sheets/detail/breast-cancer.

3. Здравоохранение в России. 2023: Стат. сб. Росстат. М., 2023. 179 с. https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2023.pdf.

4. Методические рекомендации МР 2.3.1.0253–21 «Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации», утверждены руководителем Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека – Главным государственным санитарным врачом Российской Федерации 22.07.2021. https://www.rospotrebnadzor.ru/documents/details.phpELEMENT_ID=1897.

5. Kim Y, Je Y. Tea consumption and the risks of all-cause, cardiovascular disease, and cancer mortality: a meta-analysis of 38 prospective cohort data sets. Epidemiol Health. 2024 Jun; 21: e2024056. DOI: 10.4178/epih.e2024056

6. Wang K, Li Z, He J. Association of caffeine consumption with all-cause and cause-specific mortality in adult Americans with hypertension. Food Sci Nutr. 2024 Mar 8; 12 (6): 4185–4195. DOI: 10.1002/fsn3.4079

7. Borghi C, Tsioufis K, Agabiti-Rosei E, Burnier M, Cicero AFG, Clement D, Coca A, Desideri G, Grassi G, Lovic D, Lurbe E, Kahan T, Kreutz R, Jelakovic B, Polonia J, Redon J, Van De Borne P, Mancia G. Nutraceuticals and blood pressure control: a European Society of Hypertension position document. J. Hypertens. 2020 May; 38 (5): 799–812. DOI: 10.1097/HJH.0000000000002353

8. Chan KY, Wong MMH, Pang SSH, Lo KKH. Dietary supplementation for gestational diabetes prevention and management: a meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2021 Jun; 303 (6): 1381–1391. DOI: 10.1007/s00404‑021‑06023‑9

9. Guan R, Van Le Q, Yang H, Zhang D, Gu H, Yang Y, Sonne C, Lam SS, Zhong J, Jianguang Z, Liu R, Peng W. A review of dietary phytochemicals and their relation to oxidative stress and human diseases. Chemosphere. 2021 May; 271: 129499. DOI: 10.1016/j.chemosphere.2020.129499

10. Osadnik T, Goławski M, Lewandowski P, Morze J, Osadnik K, Pawlas N, Lejawa M, Jakubiak GK, Mazur A, Schwingschackl L, Gąsior M, Banach M. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. Pharmacol Res. 2022 Sep; 183: 106402. DOI: 10.1016/j.phrs.2022.106402

11. Rosell M, Fadnes LT. Vegetables, fruits, and berries – a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2024 Jan 25; 68. DOI: 10.29219/fnr.v68.10455

12. Rodríguez-Negrete EV, Morales-González Á, Madrigal-Santillán EO, Sánchez-Reyes K, Álvarez-González I, Madrigal-Bujaidar E, Valadez-Vega C, Chamorro-Cevallos G, Garcia-Melo LF, Morales-González JA. Phytochemicals and Their Usefulness in the Maintenance of Health. Plants (Basel). 2024 Feb 15; 13 (4): 523. DOI: 10.3390/plants13040523

13. Sazali S, Badrin S, Norhayati MN, Idris NS. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis. BMJ Open. 2021 Jan 5; 11 (1): e039358. DOI: 10.1136/bmjopen‑2020–039358

14. An P, Wan S, Luo Y, Luo J, Zhang X, Zhou S, Xu T, He J, Mechanick JI, Wu WC, Ren F, Liu S. Micronutrient Supplementation to Reduce Cardiovascular Risk. J. Am. Coll. Cardiol. 2022 Dec 13; 80 (24): 2269–2285. DOI: 10.1016/j.jacc.2022.09.048

15. Moretti C, Bonomi M, Dionese P, Federici S, Fulghesu AM, Giannelli J, Giordano R, Guccione L, Maseroli E, Moghetti P, Mioni R, Pivonello R, Sabbadin C, Scaroni C, Tonacchera M, Verde N, Vignozzi L, Gambineri A. Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women’s Endocrinology. J. Endocrinol Invest. 2024 Jul 15. DOI: 10.1007/s40618–024–02363-w

16. Wei P, Liu M, Chen Y, Chen DC. Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J. Trop Med. 2012 Mar; 5 (3): 243–8. DOI: 10.1016/S 1995–7645 (12) 60033‑9

17. Singla RK, Wang X, Gundamaraju R, Joon S, Tsagkaris C, Behzad S, Khan J, Gautam R, Goyal R, Rakmai J, Dubey AK, Simal-Gandara J, Shen B. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. Crit Rev Food Sci Nutr. 2023 Nov; 63 (33): 11880–11924. DOI: 10.1080/10408398.2022.2097196

18. Steinbrecher A, Linseisen J. Dietary intake of individual glucosinolates in participants of the EPIC-Heidelberg cohort study. Ann Nutr Metab. 2009; 54 (2): 87–96. DOI: 10.1159/000209266

19. Reyes-Hernández OD, Figueroa-González G, Quintas-Granados LI, Gutiérrez-Ruíz SC, Hernández-Parra H, Romero-Montero A, Del Prado-Audelo ML, Bernal-Chavez SA, Cortés H, Peña-Corona SI, Kiyekbayeva L, Ateşşahin DA, Goloshvili T, Leyva-Gómez G, Sharifi-Rad J. 3,3’-Diindolylmethane and indole‑3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. Cancer Cell Int. 2023 Aug 26; 23 (1): 180. DOI: 10.1186/s12935‑023‑03031‑4

20. Денисова Е. Л., Королев А. А., Никитенко Е. И., Кирпиченкова Е. В., Фетисов Р. Н., Козлов В. В., Онищенко Г. Г. Гигиеническая оценка содержания индолов в рационе студентов медицинского университета. Вопр. питания. 2018. Т. 87, № 6. С. 22–27. DOI: 10.24411/00 42–88 33‑2018‑10063 https://pubmed.ncbi.nlm.nih.gov/30763487

21. Ramakrishna K, Jain SK, Krishnamurthy S. Pharmacokinetic and Pharmacodynamic Properties of Indole‑3-carbinol in experimental focal ischemic Injury. Eur. J. Drug Metab Pharmacokinet. 2022 DOI: 10.1007/s13318–022–00771-y

22. Williams DE. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole‑3-Carbinol and 3,3’-Diindolylmethane. Front Nutr. 2021 Oct 1; 8: 734334. DOI: 10.3389/fnut.2021.734334

23. Diindolylmethane (DIM) Information Resource Center. An Initiative of Faculty Members and Research Fellows at the University of California at Berkeley https://www.diindolylmethane-dim.com/references.htm

24. Centofanti F, Buono A, Verboni M, Tomino C, Lucarini S, Duranti A, Pandolfi PP, Novelli G. Synthetic Methodologies and Therapeutic Potential of Indole‑3-Carbinol (I3C) and Its Derivatives. Pharmaceuticals (Basel). 2023 Feb 5; 16 (2): 240. DOI: 10.3390/ph16020240

25. Thomson CA, Ho E, Strom MB. Chemopreventive properties of 3,3-diindolylmethane in breast cancer: evidence from experimental and human studies. Nutr Rev. 2016 Jul; 74 (7): 432–43. DOI: 10.1093/nutrit/nuw010

26. Li F, Xu Y, Chen C, Chen SM, Xiao BK, Tao ZZ. Pro-apoptotic and anti-proliferative effects of 3,3’-diindolylmethane in nasopharyngeal carcinoma cells via downregulation of telomerase activity. Mol Med Rep. 2015 Sep; 12 (3): 3815–3820. DOI: 10.3892/mmr.2015.3836

27. Herz C, Tran HTT, Landerer S, Gaus J, Schlotz N, Lehr L, Schäfer WR, Treeck O, Odongo GA, Skatchkov I, Lamy E. Normal human immune cells are sensitive to telomerase inhibition by Brassica-derived 3,3-diindolylmethane, partly mediated via ERα/β-AP1 signaling. Mol Nutr Food Res. 2017 Sep; 61 (9). DOI: 10.1002/mnfr.201600524

28. Kong D, Banerjee S, Huang W, Li Y, Wang Z, Kim HR, Sarkar FH. Mammalian target of rapamycin repression by 3,3’-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC 3 cells. Cancer Res. 2008 Mar 15; 68 (6): 1927–34. DOI: 10.1158/0008–5472.CAN‑07–3241

29. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF. 3,3’-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis. 2005 Apr; 26 (4): 771–8. DOI: 10.1093/carcin/bgi018

30. Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J, Kwon DY, Park JH. Oral administration of 3,3’-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J. Nutr. 2009 Dec; 139 (12): 2373–9. DOI: 10.3945/jn.109.111864.

31. Li WX, Chen LP, Sun MY, Li JT, Liu HZ, Zhu W. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling. Oncotarget. 2015 Sep 15; 6 (27): 23776–92. DOI: 10.18632/oncotarget.4196

32. Munakarmi S, Shrestha J, Shin HB, Lee GH, Jeong YJ. 3,3’-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis. Cells. 2021 May 12; 10 (5): 1178. DOI: 10.3390/cells10051178

33. Tsao CW, Li JS, Lin YW, Wu ST, Cha TL, Liu CY. Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3’-diindolylmethane in an enzalutamide-resistant prostate cancer cell line. Sci Rep. 2021 Jan 13; 11 (1): 1239. DOI: 10.1038/s41598‑020‑80519‑3

34. Zhu P, Yu H, Zhou K, Bai Y, Qi R, Zhang S. 3,3’-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE 2 pathway. J Exp Clin Cancer Res. 2020 Jun 16;39(1):113. DOI: 10.1186/s13046–020–01618–7.)

35. Amarakoon D, Lee WJ, Tamia G, Lee SH. Indole‑3-Carbinol: Occurrence, Health-Beneficial Properties, and Cellular/Molecular Mechanisms. Annu Rev Food Sci Technol. 2023 Mar 27; 14: 347–366. DOI: 10.1146/annurev-food‑060721–025531

36. Jayakumar P, Pugalendi KV, Sankaran M. Attenuation of hyperglycemia-mediated oxidative stress by indole‑3-carbinol and its metabolite 3, 3’- diindolylmethane in C 57BL/6J mice. J. Physiol Biochem. 2014 Jun; 70 (2): 525–34. DOI: 10.1007/s13105‑014‑0332‑5

37. Опыт применения индинола при папилломавирусной инфекции: сб. статей. – М., 2011. – 50 с. https://indinol.ru/assets/files/Sbornik_VPH_A4_out.pdf

38. Nikitina D, Llacuachaqui M, Sepkovic D, Bradlow HL, Narod SA, Kotsopoulos J. The effect of oral 3,3’-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers. Fam Cancer. 2015 Jun; 14 (2): 281–6. DOI: 10.1007/s10689‑015‑9783‑2

39. Godínez-Martínez E, Santillán R, Sámano R, Chico-Barba G, Tolentino MC, Hernández-Pineda J. Effectiveness of 3,3’-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women. Nutr Cancer. 2023; 75 (2): 510–519. DOI: 10.1080/01635581.2022.2123535

40. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3’-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer. 2004; 50 (2): 161–7. DOI: 10.1207/s15327914nc5002_5

41. Green T, See J, Schauch M, Reil J, Glover M, Brix J, Gerry A, Li K, Newman M, Gahler RJ, Wood S. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense® on 2-hydroxyestrone:16α-hydroxyestrone ratio in premenopausal women. J. Complement Integr Med. 2022 Oct 6; 20 (1): 199–206. DOI: 10.1515/jcim‑2022–0301

42. Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. 2017 Aug; 165 (1): 97–107. DOI: 10.1007/s10549‑017‑4292‑7

43. Yerushalmi R, Bargil S, Ber Y, Ozlavo R, Sivan T, Rapson Y, Pomerantz A, Tsoref D, Sharon E, Caspi O, Grubsrein A, Margel D. 3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial. Carcinogenesis. 2020 Oct 15; 41 (10): 1395–1401. DOI: 10.1093/carcin/bgaa050

44. Сайт «Международная ассоциация по патологии шейки матки и кольпоскопии». URL: https://ifcpc.org/ the International Federation of colposcopy and cervical pathology. https://ifcpc.org

45. Xue L, Pestka JJ, Li M, Firestone GL, Bjeldanes LF. 3,3’-Diindolylmethane stimulates murine immune function in vitro and in vivo. J. Nutr Biochem. 2008 May; 19 (5): 336–44. DOI: 10.1016/j.jnutbio.2007.05.004

46. Verma V, Sharma V, Singh V, Sharma S, Bishnoi AK, Chandra V, Maikhuri JP, Dwivedi A, Kumar A, Gupta G. Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells. Toxicol Appl Pharmacol. 2014 Oct 15; 280 (2): 323–34. DOI: 10.1016/j.taap.2014.08.002

47. Heath EI, Heilbrun LK, Li J, Vaishampayan U, Harper F, Pemberton P, Sarkar FH. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3’- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am. J. Transl Res. 2010 Jul 23; 2 (4): 402–11. PMID: 20733950; PMCID: PMC 2923864. https://pubmed.ncbi.nlm.nih.gov/20733950

48. Hwang C, Sethi S, Heilbrun LK, Gupta NS, Chitale DA, Sakr WA, Menon M, Peabody JO, Smith DW, Sarkar FH, Heath EI. Anti-androgenic activity of absorption-enhanced 3, 3’-diindolylmethane in prostatectomy patients. Am. J. Transl Res. 2016 Jan 15; 8 (1): 166–76. PMID: 27069550; PMCID: PMC 4759426. https://pubmed.ncbi.nlm.nih.gov/27069550

49. Pilla Reddy V, Jo H, Neuhoff S. Food constituent- and herb-drug interactions in oncology: Influence of quantitative modelling on Drug labelling. Br. J. Clin. Pharmacol. 2021 Oct; 87 (10): 3988–4000. DOI: 10.1111/bcp.14822

50. Chan WJ, Adiwidjaja J, McLachlan AJ, Boddy AV, Harnett JE. Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance. Cancer Chemother Pharmacol. 2023 Feb; 91 (2): 103–119. DOI: 10.1007/s00280-023-04504-z

51. Hussaarts KGAM, Hurkmans DP, Oomen-de Hoop E, van Harten LJ, Berghuis S, van Alphen RJ, Spierings LEA, van Rossum-Schornagel QC, Vastbinder MB, van Schaik RHN, van Gelder T, Jager A, van Leeuwen RWF, Mathijssen RHJ. Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. Cancers (Basel). 2019 Mar 22; 11 (3): 403. DOI: 10.3390/cancers11030403

52. Parkin DR, Malejka-Giganti D. Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3’-diindolylmethane and its parent compound indole‑3-carbinol. Cancer Detect Prev. 2004; 28 (1): 72–9. DOI: 10.1016/j.cdp.2003.11.006

53. Kim HW, Kim J, Kim J, Lee S, Choi BR, Han JS, Lee KW, Lee HJ. 3,3’-Diindolylmethane inhibits lipopolysaccharide-induced microglial hyperactivation and attenuates brain inflammation. Toxicol Sci. 2014 Jan; 137 (1): 158–67. DOI: 10.1093/toxsci/kft240

54. Du H, Zhang X, Zeng Y, Huang X, Chen H, Wang S, Wu J, Li Q, Zhu W, Li H, Liu T, Yu Q, Wu Y, Jie L. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway. Front Immunol. 2019 Jul 23; 10: 1620. DOI: 10.3389/fimmu.2019.01620

55. Ramakrishna K, Singh N, Krishnamurthy S. Diindolylmethane ameliorates platelet aggregation and thrombosis: In silico, in vitro, and in vivo studies. Eur J Pharmacol. 2022 Mar 15; 919: 174812. DOI: 10.1016/j.ejphar.2022.174812

56. Yang H, Seo SG, Shin SH, Min S, Kang MJ, Yoo R, Kwon JY, Yue S, Kim KH, Cheng JX, Kim JR, Park JS, Kim JH, Park JHY, Lee HJ, Lee KW. 3,3’-Diindolylmethane suppresses high-fat diet-induced obesity through inhibiting adipogenesis of pre-adipocytes by targeting USP2 activity. Mol Nutr Food Res. 2017 Oct; 61 (10). DOI: 10.1002/mnfr.201700119

57. Poornima J, Mirunalini S. Regulation of carbohydrate metabolism by indole‑3-carbinol and its metabolite 3,3’-diindolylmethane in high-fat diet-induced C 57BL/6J mice. Mol Cell Biochem. 2014 Jan; 385 (1–2): 7–15. DOI: 10.1007/s11010‑013‑1808‑2

58. Choi KM, Yoo HS. Amelioration of Hyperglycemia-Induced Nephropathy by 3,3’-Diindolylmethane in Diabetic Mice. Molecules. 2019 Dec 6; 24 (24): 4474. DOI: 10.3390/molecules24244474